Patent · US Active

Prevention of allergy at weaning

US8383587B2 · kind B2 · utility

0Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 19, 2008
Grant dateFeb 26, 2013
Priority date
Expiry dateFeb 2, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA23V2002/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nutritional composition comprising a partially hydrolysed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-β per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.